Home
About
Directory
Promoted Listings
Purchase Data
Drug Pipelines
Data Licensing
Newsletter
Contact
Bioverativ
is defunct.
Acquired by Sanofi, Jan 2018, $11.6B; Biogen's spinout hemophilia group
------------------
If you believe any of this information is incorrect, please
let us know
.